Search

Your search keyword '"Park, Sophie"' showing total 835 results

Search Constraints

Start Over You searched for: Author "Park, Sophie" Remove constraint Author: "Park, Sophie"
835 results on '"Park, Sophie"'

Search Results

51. Access to Chronic Pain Services for Adults from Minority Ethnic Groups in the United Kingdom (UK): a Scoping Review

55. Supplementary Figure Legend, Table 1 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia

56. Supplementary Figures 1 - 4 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia

59. Students’ and tutors’ experiences of remote ‘student–patient’ consultations

60. 'One Foot in the Present, One Foot in the Past:' Understanding E.M.D.R

61. Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review

62. Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

64. Total Triage Model in General Practice: A Systematic Review of the Opportunities and Challenges

66. A Trauma Treatment Grows More Mainstream

78. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network

79. Community pharmacy and general practice collaborative and integrated working: a realist review protocol

80. Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes

81. Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351

82. DNA Replication Stress Due to Loss of R-Loops in Myelodysplastic Syndromes with SF3B1 Mutation

84. Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study

90. Rôle et intérêt du dosage de l'hepcidine dans l'homéostasie du fer.

91. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.

92. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

93. Red blood cell transfusion burden in myelodysplastic syndromes ( MDS ) with ring Sideroblasts ( RS ): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies ( GFM )

94. A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's “pick a winner” trial, with the impact of somatic mutations

96. Becoming A Member of A Ward Nursing Community of Practice: Negotiating Participation Space

99. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases

Catalog

Books, media, physical & digital resources